Corient Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$6.53M Hold
84,777
0.49% 46
2022
Q2
$6.53M Buy
84,777
+4,709
+6% +$363K 0.49% 48
2022
Q1
$5.85M Buy
80,068
+7,052
+10% +$515K 0.39% 58
2021
Q4
$4.55M Buy
73,016
+6,236
+9% +$389K 0.3% 83
2021
Q3
$3.95M Sell
66,780
-186
-0.3% -$11K 0.29% 81
2021
Q2
$4.48M Sell
66,966
-309
-0.5% -$20.6K 0.33% 72
2021
Q1
$4.25M Sell
67,275
-50
-0.1% -$3.16K 0.36% 68
2020
Q4
$4.18M Buy
67,325
+1,478
+2% +$91.7K 0.42% 61
2020
Q3
$3.97M Buy
65,847
+2,647
+4% +$160K 0.46% 55
2020
Q2
$3.72M Buy
63,200
+1,952
+3% +$115K 0.45% 55
2020
Q1
$3.41M Buy
61,248
+5,509
+10% +$307K 0.54% 46
2019
Q4
$3.58M Buy
55,739
+35,111
+170% +$2.25M 0.45% 53
2019
Q3
$1.05M Buy
20,628
+8,738
+73% +$443K 0.15% 156
2019
Q2
$540K Buy
11,890
+2,875
+32% +$131K 0.08% 225
2019
Q1
$431K Buy
9,015
+127
+1% +$6.07K 0.07% 241
2018
Q4
$462K Buy
8,888
+3,331
+60% +$173K 0.08% 213
2018
Q3
$345K Hold
5,557
0.06% 223
2018
Q2
$307K Buy
5,557
+1,870
+51% +$103K 0.05% 224
2018
Q1
$233K Sell
3,687
-440
-11% -$27.8K 0.04% 233
2017
Q4
$253K Sell
4,127
-254
-6% -$15.6K 0.04% 257
2017
Q3
$279K Sell
4,381
-666
-13% -$42.4K 0.05% 232
2017
Q2
$281K Sell
5,047
-78
-2% -$4.34K 0.04% 262
2017
Q1
$279K Sell
5,125
-636
-11% -$34.6K 0.04% 262
2016
Q4
$337K Sell
5,761
-136
-2% -$7.96K 0.06% 242
2016
Q3
$318K Buy
+5,897
New +$318K 0.06% 249